CLINICAL_TRIALS
trial_result
· 2017-07-12
Clinical Trial Update: Omalizumab in the Treatment of Peanut Allergy [Phase 2]
Summary
Phase 2 trial results for omalizumab in peanut allergy have been completed, with results posted in July 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johns Hopkins University | Conditions: Food Allergy, Peanut Allergy | Phase 2 | Status: COMPLETED | Results posted: 2017-07-12